RediNews
ETFs Holding ANIP »    ANIP Historical Stock Prices »
ANIP News Video: Thu, Nov 3, 2016, 1:31 PM — Thursday Sector Laggards: Music & Electronics Stores, Drugs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ANI Pharmaceuticals is a pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include, among others: Diphenoxylate Hydrochloride and Atropine Sulfate, which is used as an adjunctive therapy in the management of diarrhea; Erythromycin Ethylsuccinate, which is used to treat infections caused by susceptible strains of designated organisms for selected diseases; Esterified Estrogen with Methyltestosterone, used to treat of moderate to severe vasomotor symptoms of menopause; and Etodolac, used to treat mild to moderate pain caused by osteoarthritis and rheumatoid arthritis, as well as other conditions. Self directed investors in ANI Pharmaceuticals Inc will be interested in keeping up with all ANI Pharmaceuticals Inc news they can find, both ANIP news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ANIP. At RediNews, we simplify this task by presenting both ANIP news releases originating from ANI Pharmaceuticals Inc itself, and ANIP news from a variety of media outlets. Visitors can browse this news online and through our ANIP RSS news feed.

ANIP News

ANIP News — Articles, Videos, & Press Releases

ANI Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ANIP
Tuesday, February 12, 2019, 4:37 PM — Market News Video
Analysts Expect EWSC Will Reach $64
Wednesday, January 30, 2019, 7:39 AM — ETF Channel
Analysts See 26% Gains Ahead For IJT
Friday, December 28, 2018, 9:47 AM — ETF Channel
Surprising Analyst 12-Month Target For IJR
Tuesday, November 27, 2018, 7:37 AM — ETF Channel
Add Up The Pieces: RZG Could Be Worth $148
Thursday, October 25, 2018, 7:32 AM — ETF Channel
Implied XPH Analyst Target Price: $58
Monday, September 24, 2018, 7:23 AM — ETF Channel
Add Up The Pieces: RZG Could Be Worth $148
Friday, August 17, 2018, 9:17 AM — ETF Channel
Notable Two Hundred Day Moving Average Cross - ANIP
Tuesday, August 7, 2018, 11:51 AM — Market News Video
Commit To Buy ANI Pharmaceuticals At $50, Earn 5.6% Annualized Using Options
Thursday, August 2, 2018, 11:54 AM — Stock Options Channel
Noteworthy Wednesday Option Activity: COWN, ANIP, ASUR
Wednesday, July 11, 2018, 3:19 PM — Stock Options Channel
Look Under The Hood: RZG Has 13% Upside
Monday, April 30, 2018, 9:07 AM — ETF Channel
SLY's Holdings Imply 10% Gain Potential
Tuesday, March 27, 2018, 9:23 AM — ETF Channel
ANIP is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

FCSC News
EGLT News
VCYT News
INGN News
TNDM News
ATEC News
BSTC News
ASPX News
EBIO News
NRCIA News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ANIP News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.